Hideaki Watanabe
Showa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Research on Epidemiology of Metal Sensitization in Japan.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: August 21, 2026
Guidelines for the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 2025 Supplement.
Journal: The Journal of dermatology
Published: November 30, 2025
Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
Journal: The Journal of dermatology
Published: May 30, 2025
Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
Journal: The Journal of dermatology
Published: December 17, 2024
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
Journal: The Journal of dermatology
Published: September 17, 2024
Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.
Journal: The British journal of dermatology
Published: July 02, 2024
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 30, 2023
Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan.
Journal: American journal of ophthalmology
Published: August 28, 2023
Baicalin target protein, Annexin A2, is a target of new antitumor drugs.
Journal: Scientific reports
Published: July 03, 2023
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Journal: The Journal of investigative dermatology
Published: June 19, 2023
Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 26, 2022
MCAM+CD161- Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 22, 2022
Last Updated: 09/26/2026